C4 Therapeutics Inc. (CCCC)
NASDAQ: CCCC
· Real-Time Price · USD
2.44
0.09 (3.83%)
At close: Aug 15, 2025, 11:01 AM
C4 Therapeutics Revenue
C4 Therapeutics reported an annual revenue of $35.58M, reflecting a 71.44% growth. For the quarter ending June 30, 2025, C4 Therapeutics generated $0 in revenue.
Revenue (ttm)
35.58M
Revenue Growth
71.44%
Price / Sales Ratio
7.02
Revenue / Employee
323.49K
Employees
110
Market Cap
173.3M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | % Change |
---|